1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Senn, H. Klaus, W. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 232 907 925 10.1006/jmbi.1993.1439 8355277 The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GP IIb-IIIa receptor. 1993 UK J.Mol.Biol. JMOBAK 0070 0022-2836 232 897 Determination of the Disulphide Bonding Pattern in Proteins by Local and Global Analysis of Nuclear Magnetic Resonance Data: Application to Flavoridin 1993 10.2210/pdb1fvl/pdb pdb_00001fvl 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 7672.710 FLAVORIDIN 1 nat polymer no no GEECDCGSPSNPCCDAATCKLRPGAQCADGLCCDQCRFKKKRTICRIARGDFPDDRCTGLSNDCPRWNDL GEECDCGSPSNPCCDAATCKLRPGAQCADGLCCDQCRFKKKRTICRIARGDFPDDRCTGLSNDCPRWNDL A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Trimeresurus sample 88087 BLOOD Trimeresurus flavoviridis database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1996-01-29 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1995-09-06 REL REL 18 GLY 1 n 1 GLY 1 A GLU 2 n 2 GLU 2 A GLU 3 n 3 GLU 3 A CYS 4 n 4 CYS 4 A ASP 5 n 5 ASP 5 A CYS 6 n 6 CYS 6 A GLY 7 n 7 GLY 7 A SER 8 n 8 SER 8 A PRO 9 n 9 PRO 9 A SER 10 n 10 SER 10 A ASN 11 n 11 ASN 11 A PRO 12 n 12 PRO 12 A CYS 13 n 13 CYS 13 A CYS 14 n 14 CYS 14 A ASP 15 n 15 ASP 15 A ALA 16 n 16 ALA 16 A ALA 17 n 17 ALA 17 A THR 18 n 18 THR 18 A CYS 19 n 19 CYS 19 A LYS 20 n 20 LYS 20 A LEU 21 n 21 LEU 21 A ARG 22 n 22 ARG 22 A PRO 23 n 23 PRO 23 A GLY 24 n 24 GLY 24 A ALA 25 n 25 ALA 25 A GLN 26 n 26 GLN 26 A CYS 27 n 27 CYS 27 A ALA 28 n 28 ALA 28 A ASP 29 n 29 ASP 29 A GLY 30 n 30 GLY 30 A LEU 31 n 31 LEU 31 A CYS 32 n 32 CYS 32 A CYS 33 n 33 CYS 33 A ASP 34 n 34 ASP 34 A GLN 35 n 35 GLN 35 A CYS 36 n 36 CYS 36 A ARG 37 n 37 ARG 37 A PHE 38 n 38 PHE 38 A LYS 39 n 39 LYS 39 A LYS 40 n 40 LYS 40 A LYS 41 n 41 LYS 41 A ARG 42 n 42 ARG 42 A THR 43 n 43 THR 43 A ILE 44 n 44 ILE 44 A CYS 45 n 45 CYS 45 A ARG 46 n 46 ARG 46 A ILE 47 n 47 ILE 47 A ALA 48 n 48 ALA 48 A ARG 49 n 49 ARG 49 A GLY 50 n 50 GLY 50 A ASP 51 n 51 ASP 51 A PHE 52 n 52 PHE 52 A PRO 53 n 53 PRO 53 A ASP 54 n 54 ASP 54 A ASP 55 n 55 ASP 55 A ARG 56 n 56 ARG 56 A CYS 57 n 57 CYS 57 A THR 58 n 58 THR 58 A GLY 59 n 59 GLY 59 A LEU 60 n 60 LEU 60 A SER 61 n 61 SER 61 A ASN 62 n 62 ASN 62 A ASP 63 n 63 ASP 63 A CYS 64 n 64 CYS 64 A PRO 65 n 65 PRO 65 A ARG 66 n 66 ARG 66 A TRP 67 n 67 TRP 67 A ASN 68 n 68 ASN 68 A ASP 69 n 69 ASP 69 A LEU 70 n 70 LEU 70 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ASP 15 A N ASP 15 A O LYS 20 A O LYS 20 A O ARG 46 A O ARG 46 A N ASP 55 A N ASP 55 1 A ARG 49 0.076 SIDE CHAIN 2 A ARG 22 0.080 SIDE CHAIN 2 A ARG 37 0.114 SIDE CHAIN 2 A ARG 56 0.103 SIDE CHAIN 3 A ARG 22 0.076 SIDE CHAIN 5 A ARG 37 0.078 SIDE CHAIN 5 A ARG 46 0.089 SIDE CHAIN 6 A ARG 49 0.085 SIDE CHAIN 7 A ARG 37 0.098 SIDE CHAIN 7 A ARG 46 0.081 SIDE CHAIN 9 A ARG 46 0.126 SIDE CHAIN 9 A ARG 49 0.118 SIDE CHAIN 10 A ARG 56 0.105 SIDE CHAIN 11 A ARG 46 0.080 SIDE CHAIN 11 A ARG 56 0.154 SIDE CHAIN 12 A ARG 42 0.115 SIDE CHAIN 13 A ARG 22 0.083 SIDE CHAIN 13 A ARG 49 0.096 SIDE CHAIN 15 A ARG 22 0.136 SIDE CHAIN 16 A ARG 22 0.108 SIDE CHAIN 18 A ARG 22 0.097 SIDE CHAIN 1 A GLU 3 -144.18 25.82 1 A ASP 5 -164.21 48.50 1 A ALA 28 -96.32 -60.06 1 A CYS 36 157.39 -35.06 1 A LEU 60 -148.52 27.79 2 A GLU 3 59.83 -179.42 2 A ASP 15 58.20 -162.53 2 A ALA 17 -168.85 -59.57 2 A THR 18 -155.35 29.47 2 A CYS 36 154.74 -32.25 2 A ARG 42 92.34 -2.80 2 A ARG 49 -103.62 74.03 2 A ASN 68 -161.80 108.27 3 A GLU 3 54.66 70.36 3 A ASP 5 -152.00 56.22 3 A THR 18 -166.50 64.76 3 A CYS 19 -35.85 -32.52 3 A GLN 35 31.68 48.53 3 A CYS 36 165.28 -51.77 3 A LYS 41 -58.47 177.73 3 A ASP 51 -97.24 40.70 3 A THR 58 -99.81 -66.94 3 A ASP 69 51.10 83.88 4 A ASP 5 -145.04 27.37 4 A ALA 16 24.98 71.01 4 A ALA 17 -158.24 -63.40 4 A GLN 26 -146.33 23.37 4 A GLN 35 31.03 57.81 4 A LEU 60 -142.22 39.05 5 A GLU 3 62.40 -179.59 5 A CYS 4 66.74 120.56 5 A SER 10 -96.57 40.86 5 A ALA 17 -153.95 -57.69 5 A CYS 19 75.96 -0.60 5 A CYS 27 -170.80 -178.07 5 A LEU 31 59.08 6.40 5 A CYS 32 -151.25 25.93 5 A CYS 36 171.73 40.04 5 A ARG 37 -176.71 -174.64 5 A ASP 51 -96.12 41.13 6 A ASP 15 59.11 -173.65 6 A ALA 17 -153.64 -58.04 6 A THR 18 -160.66 31.61 6 A CYS 19 79.77 -40.20 6 A ALA 28 -127.69 -55.13 6 A GLN 35 -82.54 45.97 6 A CYS 36 171.80 -39.55 6 A ARG 42 87.55 35.28 6 A ASP 51 -104.48 43.73 7 A GLU 2 -64.17 99.29 7 A ASP 5 -150.66 35.06 7 A CYS 6 -114.62 -75.12 7 A THR 18 -157.10 60.50 7 A CYS 32 -109.78 40.87 7 A LYS 41 -56.07 177.00 7 A ARG 49 -109.36 63.10 7 A ASP 51 -101.81 43.02 7 A CYS 57 -81.69 -159.03 8 A GLU 3 -159.11 68.41 8 A ASP 5 -148.34 28.26 8 A ALA 16 27.37 69.01 8 A ALA 17 -163.42 -70.34 8 A GLN 35 32.51 42.35 8 A CYS 36 159.30 -53.21 8 A ARG 42 80.63 16.05 8 A ASP 51 -94.92 38.29 8 A LEU 60 -100.04 40.43 8 A ASN 68 41.39 -148.73 9 A CYS 19 76.31 -1.45 9 A LEU 21 -46.53 151.59 9 A GLN 35 31.37 44.89 9 A CYS 36 154.34 -55.24 9 A ARG 42 89.93 3.73 9 A LEU 60 -159.65 28.36 9 A ASP 69 -142.67 29.71 10 A GLU 3 -160.38 64.80 10 A ASP 5 -153.65 50.95 10 A ALA 16 31.38 55.88 10 A ALA 17 -167.46 -55.10 10 A CYS 19 58.44 16.50 10 A GLN 35 -80.14 47.51 10 A CYS 36 157.32 -32.11 10 A ARG 42 81.45 13.78 11 A GLU 3 62.75 169.82 11 A CYS 4 65.53 120.41 11 A ASP 5 -156.73 42.77 11 A ASP 34 -167.17 55.97 11 A GLN 35 -171.97 41.08 11 A ARG 37 -172.34 -172.20 11 A LYS 40 60.75 170.27 11 A ARG 42 83.33 33.39 11 A CYS 57 -78.72 -169.48 11 A ASN 68 -170.32 71.56 12 A GLU 3 70.87 128.53 12 A CYS 4 64.80 124.80 12 A ASP 5 -150.10 41.90 12 A ALA 16 29.30 62.00 12 A ALA 17 -162.94 -65.43 12 A GLN 35 32.72 43.19 12 A CYS 36 165.42 -47.79 12 A LYS 40 -49.36 160.50 12 A ARG 42 85.26 16.23 12 A ASP 51 -101.73 43.38 12 A LEU 60 -140.68 16.82 13 A CYS 6 -136.53 -86.57 13 A SER 10 -89.33 39.22 13 A GLN 35 32.34 55.66 13 A ARG 37 -171.93 -171.14 13 A LYS 41 -55.95 174.64 13 A ASP 51 -100.06 41.62 13 A LEU 60 -151.18 29.16 14 A CYS 4 163.70 127.20 14 A ASP 15 56.77 -173.16 14 A ALA 17 -158.85 -58.16 14 A THR 18 -160.12 32.05 14 A CYS 19 79.11 -44.92 14 A CYS 36 152.76 -29.75 14 A ARG 37 -129.35 -167.86 14 A ARG 42 82.53 16.66 14 A ARG 49 -103.89 65.33 14 A ASP 51 -103.33 43.44 14 A ASN 68 31.73 -146.98 14 A ASP 69 -98.06 42.07 15 A ASP 5 -153.04 32.48 15 A ALA 16 -98.86 36.43 15 A ASP 29 -173.42 142.82 15 A CYS 32 -149.77 25.78 15 A GLN 35 31.75 42.71 15 A CYS 36 154.96 -52.50 15 A ARG 37 -103.10 -165.93 15 A LEU 60 -88.15 39.11 16 A GLU 2 -57.07 171.00 16 A GLU 3 -161.39 102.55 16 A ASP 15 53.31 -164.39 16 A ALA 17 -165.45 -57.45 16 A THR 18 -159.03 31.22 16 A CYS 19 72.19 -1.19 16 A ALA 28 -123.86 -57.67 16 A CYS 36 153.01 -29.72 16 A LYS 41 -60.73 -174.11 16 A ARG 42 74.77 39.53 16 A LEU 60 -87.70 33.60 17 A GLU 2 -159.24 54.30 17 A CYS 4 179.10 123.22 17 A CYS 6 -135.01 -73.94 17 A THR 18 -158.84 59.57 17 A ASP 29 179.91 161.80 17 A ASP 34 -157.07 53.80 17 A GLN 35 -171.01 33.07 17 A ARG 37 -170.13 -173.20 17 A LYS 41 -59.21 178.66 17 A ASP 51 -97.65 40.65 18 A GLU 2 -162.35 66.66 18 A GLU 3 67.70 137.87 18 A CYS 4 63.50 116.38 18 A ASP 5 -157.55 37.77 18 A CYS 6 -115.63 -82.85 18 A LEU 31 55.27 12.23 18 A CYS 32 -150.78 -37.80 18 A CYS 36 158.67 -32.87 18 A LYS 41 -55.04 174.84 18 A LEU 60 -96.74 41.79 18 A ASN 68 -171.78 47.73 18 A ASP 69 49.64 85.17 THE NUCLEAR MAGNETIC RESONANCE SOLUTION STRUCTURE OF FLAVORIDIN, AN ANTAGONIST OF THE PLATELET GP IIB-IIIA RECEPTOR 1 Y N disulf 2.092 A CYS 4 A SG CYS 4 1_555 A CYS 19 A SG CYS 19 1_555 disulf 2.046 A CYS 6 A SG CYS 6 1_555 A CYS 14 A SG CYS 14 1_555 disulf 2.019 A CYS 13 A SG CYS 13 1_555 A CYS 36 A SG CYS 36 1_555 disulf 2.013 A CYS 27 A SG CYS 27 1_555 A CYS 33 A SG CYS 33 1_555 disulf 2.048 A CYS 32 A SG CYS 32 1_555 A CYS 57 A SG CYS 57 1_555 disulf 1.945 A CYS 45 A SG CYS 45 1_555 A CYS 64 A SG CYS 64 1_555 BLOOD COAGULATION INHIBITOR GP IIB/IIIA ANTAGONIST, BLOOD COAGULATION INHIBITOR DISF_TRIFL UNP 1 1 P18619 GEECDCGSPSNPCCDAATCKLRPGAQCADGLCCDQCRFKKKRTICRIARGDFPDDRCTGLSNDCPRWNDL 1 70 1FVL 1 70 P18619 A 1 1 70 2 2 anti-parallel anti-parallel A CYS 14 A CYS 14 A ASP 15 A ASP 15 A LYS 20 A LYS 20 A LEU 21 A LEU 21 A ILE 44 A ILE 44 A ARG 46 A ARG 46 A ASP 55 A ASP 55 A ARG 56 A ARG 56 1 P 1